Komentář k článku v časopise Gut
Screening jaterního poškození u pacientů s diabetes mellitus 2. typu

Czech version

Authors: R. Brůha
Authors‘ workplace: IV. interní klinika 1. LF UK a VFN v Praze
Published in: Gastroent Hepatol 2015; 69(4): 365-367
Category: Hepatology: Commentary
doi: https://doi.org/10.14735/amgh2015365

Sources

Literatura

1. Kwok R, Choi KC, Wong GL et al. Screening diabetic patients for non‑alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut 2015. doi: 10.1136/ gutjnl‑ 2015‑ 309265. In press.

2. Dvořák K. Možnosti neinvazivní diagnostiky u NAFLS. Gastroent Hepatol 2015; 69(2): 110– 115. doi:10.14735/amgh2015110.

3. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non‑alcoholic fatty liver disease and non‑alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34(3): 274– 285. doi: 10.1111/ j.1365‑ 2036.2011.04724.x.

4. Adams LA, Lymp JF, St Sauver J et al. The natural history of nonalcoholic fatty liver disease: a population‑based cohort study. Gastroenterology 2005; 129(1): 113– 121.

5. Caldwell S, Argo C. The natural history of non‑alcoholic fatty liver disease. Dig Dis 2010; 28(1): 162– 168. doi: 10.1159/ 000282081.

6. Dvorak K, Hainer R, Petrtyl J et al. The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2014. doi: 10.5507/ bp.2014.033.